PT Darya-Varia Laboratoria Tbk

Short Term Long Term Short Term Comparison Long Term Comparison
  • DVLA
  • 1d-3.00%
  • 1w0.00%
  • 1m2.46%
  • 1y-20.57%
ATH
  • ATH Price$516,332.00
  • ATH Date1995-10-23
  • % since ATH-99.72%
  • % to ATH35,386.74%
ATL
  • ATL Price$98.10
  • ATL Date2002-07-26
  • % from ATL1,383.14%
  • Last Low Price$98.103
  • Last Low Date2002-07-26
  • % From Last Low1,383.14%
IPO
  • IPO Price$1,000,000.00
  • % Current ROI USD-99.85%
  • ATH Price$516,332.00
  • % ROI ATH 52,631,621.87%
Share

Graph takes few seconds to load...

Key Data
Share

Current price $1455
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Today's High/Low $1525/$1450
Volume 240,100.00
Previous Close $1500
52 Week High/Low $2057.4/$1365.1
Market Cap 1,629,599,956,992.00
P/E Ratio 11.1111
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0.0832
$1455
Share

PT Darya-Varia Laboratoria Tbk engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia and internationally.
It operates in three segments: Prescription Drugs, Consumer Health Products, and Export and Toll Manufacturing Services.
It provides various prescription and consumer health products in antibiotic, antiparasit, antiseptic, anti-fungal, cough and cold, cardiology, central nervous system, gastro-hepatology, somatic, vitamin and food supplement, women healthcare, ear healthcare, and derma medic areas.
The company was founded in 1976 and is headquartered in Jakarta, Indonesia. PT Darya-Varia Laboratoria Tbk is a subsidiary of Blue Sphere Singapore Pte. Ltd.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity